Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

U S Physical Therapy (USPH) EBITDA (2017 - 2023)

Historic EBITDA for U S Physical Therapy (USPH) over the last 11 years, with Q4 2023 value amounting to -$4.3 million.

  • U S Physical Therapy's EBITDA fell 24538.93% to -$4.3 million in Q4 2023 from the same period last year, while for Dec 2023 it was $36.0 million, marking a year-over-year decrease of 2407.25%. This contributed to the annual value of $45.6 million for FY2024, which is 2672.09% up from last year.
  • U S Physical Therapy's EBITDA amounted to -$4.3 million in Q4 2023, which was down 24538.93% from $13.2 million recorded in Q3 2023.
  • In the past 5 years, U S Physical Therapy's EBITDA registered a high of $22.2 million during Q2 2021, and its lowest value of -$4.3 million during Q4 2023.
  • Moreover, its 5-year median value for EBITDA was $14.9 million (2021), whereas its average is $13.5 million.
  • In the last 5 years, U S Physical Therapy's EBITDA soared by 27424.02% in 2021 and then plummeted by 24538.93% in 2023.
  • U S Physical Therapy's EBITDA (Quarter) stood at $15.3 million in 2019, then increased by 19.08% to $18.2 million in 2020, then decreased by 20.65% to $14.4 million in 2021, then crashed by 79.73% to $2.9 million in 2022, then tumbled by 245.39% to -$4.3 million in 2023.
  • Its EBITDA stands at -$4.3 million for Q4 2023, versus $13.2 million for Q3 2023 and $17.0 million for Q2 2023.